Mohammed Azman – CEO, PERKESO, Malaysia
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Address: T2-9, Jaya 33, No 3 (Lot 33), Jalan Semangat, Seksyen 13, Petaling Jaya, Selangor
,Malaysia
Tel: 603 – 7718 1600
Web: http://www.msd-malaysia.com/
MSD in Malaysia is the local subsidiary of Merck & Co., Inc., a leading research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of innovative health care products. The local office was established in 1997 and currently employs over 300 people.
MSD is committed to maintaining and improving the quality of human life above all else. As one of the leading research-based pharmaceutical companies in Malaysia, MSD markets and sells a wide selection of prescription pharmaceutical products to doctors and pharmacists.
MSD is now a leader in a broad range of areas, including cardiology, infectious diseases, diabetes, respiratory, vaccines, women’s health, sun care and animal health, and is also expanding its offerings in other areas, such as neurology, oncology and dermatology.
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Jennifer Lopez, executive director of the British Malaysian Chamber of Commerce, discusses foreign investment trends in Malaysia and how the chamber is serving its members, especially UK companies operating in…
Lim Teng Chyuan, president of the Malaysian Association for Pharmaceutical Suppliers (MAPS), discusses the association’s role in solving and supporting its members with the numerous regulatory issues and compliance requirements…
Amrahi Buang, president of the Malaysian Pharmaceutical Society details the ‘lack’ of recognition and integration of pharmacists in Malaysia. He also explains the complex dual healthcare system and the governmental…
The managing director of Boston Consulting Group Malaysia discusses the gap between public and private healthcare in the country, and what can be done to bridge it. What appears…
Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region…
Rhenu Bhuller provides insight into Malaysia’s healthcare industry positioning in the Southeast Asian region and the ability to provide affordable quality healthcare in a country that is naturally diverse as…
Klaus Boehncke and Yennie Tan from PwC Malaysia discuss the factors that will make the country a hub for medical tourism and the importance of listening to patient demands at…
Dr. Hassan, founder and CEO of Healwell and House of Healin, brings research and entrepreneurship together with the aim of turning Malaysian traditions into scientific innovation. Could you share…
Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the Malaysian clinical trial segment and describes INC’s…
Bayer Malaysia’s managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more information to help the promotion of oral contraception in…
Sanofi’s general manager for Malaysia, Singpoare and Brunei discusses the benefits of implementing of a new channel business model and proudly showcases the dengue vaccine, 20 years after the company initiated…
See our Cookie Privacy Policy Here
